139 related articles for article (PubMed ID: 2565342)
1. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma.
Frohman LA; Downs TR; Heimer EP; Felix AM
J Clin Invest; 1989 May; 83(5):1533-40. PubMed ID: 2565342
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolic degradation of a bovine growth hormone-releasing factor analog Leu27-bGRF(1-29)NH2 in bovine and porcine plasma. Correlation with plasma dipeptidylpeptidase activity.
Kubiak TM; Kelly CR; Krabill LF
Drug Metab Dispos; 1989; 17(4):393-7. PubMed ID: 2571478
[TBL] [Abstract][Full Text] [Related]
3. Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus.
Frohman LA; Downs TR; Williams TC; Heimer EP; Pan YC; Felix AM
J Clin Invest; 1986 Oct; 78(4):906-13. PubMed ID: 3093533
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of mouse growth hormone-releasing factor, mGRF(1-42)OH, and selected analogs from the bovine GRF series in mouse and bovine plasma in vitro.
Kubiak TM; Martin RA; Leone JW; Cleary DL
Pept Res; 1994; 7(3):153-61. PubMed ID: 7915920
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase IV (DPP-IV) from pig kidney cleaves analogs of bovine growth hormone-releasing factor (bGRF) modified at position 2 with Ser, Thr or Val. Extended DPP-IV substrate specificity?
Martin RA; Cleary DL; Guido DM; Zurcher-Neely HA; Kubiak TM
Biochim Biophys Acta; 1993 Aug; 1164(3):252-60. PubMed ID: 8102071
[TBL] [Abstract][Full Text] [Related]
6. Distribution of growth hormone-releasing hormone-like immunoreactivity in human tissue extracts.
Shibasaki T; Kiyosawa Y; Masuda A; Nakahara M; Imaki T; Wakabayashi I; Demura H; Shizume K; Ling N
J Clin Endocrinol Metab; 1984 Aug; 59(2):263-8. PubMed ID: 6429182
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs.
Bongers J; Lambros T; Ahmad M; Heimer EP
Biochim Biophys Acta; 1992 Jul; 1122(2):147-53. PubMed ID: 1353684
[TBL] [Abstract][Full Text] [Related]
8. Processing and metabolism of peptide-YY: pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11.
Medeiros MD; Turner AJ
Endocrinology; 1994 May; 134(5):2088-94. PubMed ID: 7908871
[TBL] [Abstract][Full Text] [Related]
9. Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor-alpha.
Bauvois B; Sancéau J; Wietzerbin J
Eur J Immunol; 1992 Apr; 22(4):923-30. PubMed ID: 1348032
[TBL] [Abstract][Full Text] [Related]
10. Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences.
Campbell RM; Stricker P; Miller R; Bongers J; Liu W; Lambros T; Ahmad M; Felix AM; Heimer EP
Peptides; 1994; 15(3):489-95. PubMed ID: 7937325
[TBL] [Abstract][Full Text] [Related]
11. The involvement of dipeptidyl peptidase IV in brush-border degradation of GRF(1-29)NH2 by intestinal mucosal cells.
Bai JP; Chang LL
J Pharm Pharmacol; 1995 Aug; 47(8):698-701. PubMed ID: 8583376
[TBL] [Abstract][Full Text] [Related]
12. In vitro stability of growth hormone releasing factor (GRF) analogs in porcine plasma.
Su CM; Jensen LR; Heimer EP; Felix AM; Pan YC; Mowles TF
Horm Metab Res; 1991 Jan; 23(1):15-21. PubMed ID: 1826667
[TBL] [Abstract][Full Text] [Related]
13. Human growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cells.
Coy DH; Hocart SJ; Murphy WA
Eur J Pharmacol; 1991 Nov; 204(2):179-85. PubMed ID: 1806385
[TBL] [Abstract][Full Text] [Related]
14. Effects of human pancreatic tumor growth hormone-releasing hormone (hpGRH1-44-NH2) on immunoreactive and bioactive plasma growth hormone in normal young men.
Sassolas G; Chatelain P; Cohen R; Boissel JP; Laporte S; Galleyrand J; Claustrat B; Elmcharfi A; Chayvialle JA; Cohen H
J Clin Endocrinol Metab; 1984 Oct; 59(4):705-9. PubMed ID: 6148353
[TBL] [Abstract][Full Text] [Related]
15. Tryptic hydrolysis of hGH-RH(1-29)-NH2 analogues containing Lys or Orn in positions 12 and 21.
Witkowska E; Orłowska A; Sagan B; Smoluch M; Izdebski J
J Pept Sci; 2001 Mar; 7(3):166-72. PubMed ID: 11297353
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
Bernardini F; Warburton MJ
Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
[TBL] [Abstract][Full Text] [Related]
17. Analysis of aminopeptidase and dipeptidylpeptidase IV from the entomopathogenic fungus Metarhizium anisopliae.
St Leger RJ; Cooper RM; Charnley AK
J Gen Microbiol; 1993 Feb; 139(2):237-43. PubMed ID: 8094738
[TBL] [Abstract][Full Text] [Related]
18. Tryptic digestion of peptides corresponding to modified fragments of human growth hormone-releasing hormone.
Witkowska E; Orłowska A; Izdebski J
Acta Biochim Pol; 2004; 51(1):51-6. PubMed ID: 15094824
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic degradation of rat growth hormone-releasing factor(1-29) amide in rat pituitary and hypothalamus.
Boulanger L; Lazure C; Lefrançois L; Gaudreau P
Brain Res; 1993 Jul; 616(1-2):39-47. PubMed ID: 8395307
[TBL] [Abstract][Full Text] [Related]
20. Stepwise cleavage of the pro part of promelittin by dipeptidylpeptidase IV. Evidence for a new type of precursor--product conversion.
Kreil G; Haiml L; Suchanek G
Eur J Biochem; 1980 Oct; 111(1):49-58. PubMed ID: 7002560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
